BR9914250B1 - compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado. - Google Patents

compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado.

Info

Publication number
BR9914250B1
BR9914250B1 BRPI9914250-3A BR9914250A BR9914250B1 BR 9914250 B1 BR9914250 B1 BR 9914250B1 BR 9914250 A BR9914250 A BR 9914250A BR 9914250 B1 BR9914250 B1 BR 9914250B1
Authority
BR
Brazil
Prior art keywords
compounds
preparing
therapeutic use
formulation containing
cosmetic formulation
Prior art date
Application number
BRPI9914250-3A
Other languages
English (en)
Other versions
BR9914250A (pt
Inventor
Rudolf Zink
Dieter Reinehr
Helmut Luther
Bernd Herzog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9914250A publication Critical patent/BR9914250A/pt
Publication of BR9914250B1 publication Critical patent/BR9914250B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • C07C45/74Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/683Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings having unsaturation outside the aromatic rings
BRPI9914250-3A 1998-10-02 1999-09-21 compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado. BR9914250B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98810992 1998-10-02
PCT/EP1999/006985 WO2000020384A1 (en) 1998-10-02 1999-09-21 Diphenyl compounds substituted by camphor or hydantoin derivatives as sunscreen compositions

Publications (2)

Publication Number Publication Date
BR9914250A BR9914250A (pt) 2001-06-19
BR9914250B1 true BR9914250B1 (pt) 2012-08-21

Family

ID=8236366

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9914250-3A BR9914250B1 (pt) 1998-10-02 1999-09-21 compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado.

Country Status (10)

Country Link
US (1) US6384284B1 (pt)
EP (1) EP1117638B1 (pt)
JP (1) JP4471497B2 (pt)
KR (1) KR100634215B1 (pt)
CN (1) CN1264813C (pt)
AU (1) AU6193999A (pt)
BR (1) BR9914250B1 (pt)
DE (1) DE69915658D1 (pt)
ES (1) ES2216569T3 (pt)
WO (1) WO2000020384A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044341A1 (fr) * 1999-01-28 2000-08-03 Shiseido Company, Ltd. Compositions destinees a un usage externe
DE10061360A1 (de) * 2000-12-09 2002-06-13 Beiersdorf Ag Verwendung von wasserlöslichen, filmbildenden Polymeren zur Verstärkung des Lichtschutzfaktors und/oder der UV-A-Schutzleistung kosmetischer oder dermatologischer Formulierungen
EP1423351A2 (en) * 2001-09-07 2004-06-02 Ciba SC Holding AG Biphenylene compounds
US20070238814A1 (en) * 2006-04-10 2007-10-11 Basf Corporation Method of making coating compositions
GB201607831D0 (en) * 2016-05-05 2016-06-22 Landa Labs 2012 Ltd UV protective compositions and their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2415819A1 (de) * 1974-04-01 1975-10-16 Basf Ag Azlactonfarbstoffe
US4797493A (en) 1986-04-22 1989-01-10 Ajinomoto Co., Inc. Benzylidene compounds
LU87394A1 (fr) * 1988-11-22 1990-06-12 Oreal Sels de metaux polyvalents de derives sulfones du benzylidene-camphre et leur utilisation pour la protection de la peau contre le rayonnement ultraviolet
DE4426216A1 (de) 1994-07-23 1996-01-25 Merck Patent Gmbh Benzyliden-Norcampher-Derivate
DE4442324A1 (de) 1994-11-29 1996-05-30 Merck Patent Gmbh Bis(methyliden)-phenylen-Derivate

Also Published As

Publication number Publication date
US6384284B1 (en) 2002-05-07
JP4471497B2 (ja) 2010-06-02
CN1264813C (zh) 2006-07-19
CN1321145A (zh) 2001-11-07
WO2000020384A1 (en) 2000-04-13
BR9914250A (pt) 2001-06-19
DE69915658D1 (de) 2004-04-22
KR20010075554A (ko) 2001-08-09
ES2216569T3 (es) 2004-10-16
EP1117638A1 (en) 2001-07-25
EP1117638B1 (en) 2004-03-17
AU6193999A (en) 2000-04-26
JP2002526525A (ja) 2002-08-20
KR100634215B1 (ko) 2006-10-24

Similar Documents

Publication Publication Date Title
BR9909995B1 (pt) composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9912109B1 (pt) compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
PT955995E (pt) Utilizacao de complexos para a preparacao de composicoes de tratamento para peles sensiveis, processo de preparacao e compisicoes hipoalergenicas
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9806870B1 (pt) composto amidino, formulação farmacêutica, uso de um composto, e, processo papa preparar o mesmo.
NO973923L (no) Nye taxoider, deres fremstilling samt farmasöytiske preparater inneholdende forbindelsene
BR9801652B1 (pt) resorcinil-triazina, processo para preparaÇço e uso da mesma e composiÇço cosmÉtica.
BR9100517A (pt) Derivados de 3-aril-pirrolidino-2,4-diona,processo para sua preparacao,composicao inseticida,acaricida e herbicida,processo para preparacao de composicoes inseticidas
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
FI971524A0 (fi) Bentsopyraani- ja bentsofuusioituneita yhdisteitä, niiden valmistus ja niiden käyttö leukotrieeni-B4(LTB4)-antagonisteina
FI103704B1 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
BR9710739B1 (pt) polissacarÍdeos sintÉticos, processo para sua preparaÇço, composiÇÕes farmacÊuticas que os contÊm e utilizaÇço dos mesmos.
BR9712058B1 (pt) formulações para uso de ivermectina, processo para sua preparação e uso.
BR9713977B1 (pt) composto análogo de comptotecina, e, utilização e processo para preparação do mesmo.
FI971523A0 (fi) Bentsopyraani- ja bentsofuusioituja yhdisteitä, niiden valmistus ja käyttö leukotrieeni B4':n (LTB4) antagonisteina
DE69821977D1 (de) Flüssige, insektizide aufgiessformulierung
EE200000651A (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
BR9809855B1 (pt) mistura fungicida, processo para controle de fungos daninhos, uso do composto, e, composiÇço.
BR9602025A (pt) Composto composição farmacêutica uso e processo para a preparação de um composto
BR0106111B1 (pt) "copolìmeros de isobuteno isopreno, halogenados, processo para preparação dos mesmos e composto que os contém".
BR9914250B1 (pt) compostos de bifenila substituìdos por cánfora ou derivados de hidantoìna, processo de preparação dos referidos compostos, formulação cosmética contendo os mesmos e uso não terapêutico relacionado.
EE03996B1 (et) Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 21/08/2012, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: C07C 309/24 (2006.01), A61K 8/35 (2006.0

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2599 DE 27-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.